Small pharma inc sedar

Author: uqcm

August undefined, 2024

WebJul 15, 2024 · Small Pharma is advancing a pipeline of DMT-based therapies and is leading the world’s first DMT clinical trial for depression, in collaboration with Imperial College … WebApr 29, 2024 · About Small Pharma Inc. The Company is a neuropharmaceutical company specialised in IP led development of novel treatments for mental health conditions, in …

Small Pharma Reports Fiscal Second Quarter 2024 Highlights

WebJan 25, 2024 · Small Pharma Inc. George Tziras, Chief Executive Officer Email: [email protected] Tel: +1 (646) 751-4363 Investor Relations Contacts: Eric Ribner … WebApr 29, 2024 · A copy of the early warning report providing further details of Mr. Rands’ holdings will be available on the Company’s SEDAR profile at www.sedar.com. A copy of this report can be obtained by contacting Peter Rands, Chief Executive Officer, at +44 (0)2071 129118. About Small Pharma Inc. bishop bill hammond

Small Pharma Reports Fiscal Third Quarter 2024 Highlights

WebMay 31, 2024 · SMALL PHARMA INC. (FORMERLY, UNILOCK CAPITAL CORP.) Management's Discussion and Analysis of Financial Condition and Results of Operations For the three months ended May 31, 2024 Date: July 14, 2024 SMALL PHARMA INC. Management's Discussion and Analysis WebJul 15, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-acting psychedelics with therapy for the treatment of mental health conditions, with a current focus on depression.... WebGLOBAL BRIDGE Pharmaceutical is a licensed pharmaceutical consulting and procurement company based in Charlotte, NC. We supply pharmaceutical products to providers, clinics … dark gray loveseat cover

Investor Relations - Download Investor Deck - Small Pharma

WebApr 12, 2024 · SOUTH SAN FRANCISCO, Calif., and VANCOUVER, Canada, April 12, 2024 /PRNewswire/ - ESSA Pharma Inc. , a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment... April 12, 2024 WebJul 17, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-acting psychedelics with therapy for the treatment of mental health conditions, with a current focus on depression. Small Pharma initiated a clinical program into DMT-assisted psychotherapy in February 2024. bishop bill hamon 2021WebJan 25, 2024 · LONDON, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-duration... bishop bill hamon 2020

"WebSep 17, 2024 · ESSA Pharma Inc. ("ESSA", or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company has entered into a clinical trial support agreement (the "Agreement") with Janssen Research & Development, LLC ("Janssen") to enable evaluation … " - Small pharma inc sedar

Small pharma inc sedar

WebMar 19, 2024 · Small Pharma Inc. (DMT) TSXV Stock Price TMX Money DMT $0.085 -10.526% Jr. Healthcare Stock: DMT Exchange: TSXV Sector: Healthcare Industry: … WebJun 9, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-acting psychedelics with therapy for the treatment of mental health conditions, with a current focus on depression....

Did you know?

WebJun 9, 2024 · Small Pharma is advancing a pipeline of DMT-based therapies and is leading the most advanced clinical trial in commercial development for DMT-assisted psychotherapy in MDD. For further information contact: Small Pharma Inc. Peter Rands Chief Executive Officer Email: [email protected] Tel: +44 (0)20 7112 9118 WebSep 21, 2024 · LONDON, Sept. 21, 2024 /PRNewswire/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small Pharma"), a neuropharmaceutical company focused on psychedelic-assisted therapies, today announced ...

WebOct 14, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-acting psychedelic assisted therapies for the treatment of mental health conditions. The Company’s current focus is on exploring new therapeutic approaches for depression. Small Pharma’s lead candidate, SPL026, is a proprietary synthetic formulation of DMT. WebStay up-to-date with Small Pharma. We receive many enquiries about participation in our clinical trials with SPL026. However, we do not accept clinical trial participants directly …

WebAug 3, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-acting psychedelics with therapy for the treatment of mental health conditions, with a current focus on depression. Small Pharma initiated a clinical program into DMT-assisted psychotherapy in February 2024. WebMar 14, 2024 · SEDI Insider filings SEDAR Documents Short history Community Wiki Website. Last updated 2024/04/03 11:14 AM ⓘ • Turn off ads with a Pro subscription • Advertise on CEO.CA. Market Depth. Get CEO.CA Pro. Real-time Level 2 …

WebAug 3, 2024 · Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2024. LONDON, June 09, 2024 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, has today published …

WebOct 14, 2024 · MHRA approval for new SPL026 trial. LONDON, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Small Pharma Inc. DMT. DMTTF. (the " Company " or " Small Pharma "), a biotechnology company focused on short-acting ... bishop bill hamon scandalWebMar 30, 2024 · SMALL PHARMA INC. : All Information and News DMTTF CA8316641072 MarketScreener Homepage Equities United States OTC Markets Small Pharma Inc. News All News DMTTF CA8316641072 SMALL PHARMA INC. (DMTTF) Add to my list Report Summary Quotes Charts News Ratings Calendar Company Financials Consensus … dark gray marble countertopsWebFeb 15, 2024 · Small Pharma is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Small Pharma’s performance made by these … bishop bill hamon ageWebApr 12, 2024 · About ESSA Pharma Inc. ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma. Forward-Looking Statement Disclaimer bishop bill hamon wikipediaWebTeam - Small Pharma We’re a highly qualified, passionate and driven team who are on a mission to accelerate the possibility of delivering transformative treatments that matter to millions. Board and executive George Tziras Chief Executive Officer Dr Carol Routledge Chief Medical & Scientific Officer Alastair Riddell Chief Operating Officer dark gray matte nail polishWebAug 31, 2024 · LONDON, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) ... 2024. A full copy of the financial results can be found under the Company’s profile on SEDAR at www.sedar.com. Unless otherwise indicated, all currency references are in Canadian dollars. Financial Highlights (including post-period events): ... bishop billsboroughWebSmall Pharma Inc. (formerly, Unilock Capital Corp.) Apr 4 2024 07:41:58 ET News release - English PDF 101 K Mar 7 2024 08:10:44 ET News release - English PDF 20 K Mar 7 2024 … bishop bill mcalilly